![Antagonistic network signature of motor function in Parkinson's disease revealed by connectome-based predictive modeling | npj Parkinson's Disease Antagonistic network signature of motor function in Parkinson's disease revealed by connectome-based predictive modeling | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-022-00315-w/MediaObjects/41531_2022_315_Fig1_HTML.png)
Antagonistic network signature of motor function in Parkinson's disease revealed by connectome-based predictive modeling | npj Parkinson's Disease
![Predicting the longitudinal changes of levodopa dose requirements in Parkinson's disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale - Chae - 2021 - CPT: Pharmacometrics & Systems Predicting the longitudinal changes of levodopa dose requirements in Parkinson's disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale - Chae - 2021 - CPT: Pharmacometrics & Systems](https://ascpt.onlinelibrary.wiley.com/cms/asset/8464faff-f4d3-4dcc-811f-caff143eebf2/psp412632-fig-0001-m.jpg)
Predicting the longitudinal changes of levodopa dose requirements in Parkinson's disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale - Chae - 2021 - CPT: Pharmacometrics & Systems
![Frontiers | Levodopa-Induced Changes in Electromyographic Patterns in Patients with Advanced Parkinson's Disease Frontiers | Levodopa-Induced Changes in Electromyographic Patterns in Patients with Advanced Parkinson's Disease](https://www.frontiersin.org/files/MyHome%20Article%20Library/275897/275897_Thumb_400.jpg)
Frontiers | Levodopa-Induced Changes in Electromyographic Patterns in Patients with Advanced Parkinson's Disease
![Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/ce65f4e5-be82-4b1c-9682-f5ab340ee17b/mdc312553-fig-0001-m.jpg)
Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library
![Frontiers | Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease Frontiers | Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease](https://www.frontiersin.org/files/Articles/355629/fneur-09-00260-HTML/image_m/fneur-09-00260-t001.jpg)
Frontiers | Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease
![A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson's disease | Journal of Neurology, Neurosurgery & Psychiatry A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson's disease | Journal of Neurology, Neurosurgery & Psychiatry](https://jnnp.bmj.com/content/jnnp/93/6/617/F2.large.jpg)
A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson's disease | Journal of Neurology, Neurosurgery & Psychiatry
![PDF) A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson's disease PDF) A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson's disease](https://i1.rgstatic.net/publication/359830745_A_composite_clinical_motor_score_as_a_comprehensive_and_sensitive_outcome_measure_for_Parkinson's_disease/links/62e3354b9d410c5ff36b8a28/largepreview.png)
PDF) A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson's disease
![Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. - Abstract - Europe PMC Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5761650/bin/nihms886783f1.jpg)
Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. - Abstract - Europe PMC
![Antagonistic network signature of motor function in Parkinson's disease revealed by connectome-based predictive modeling | npj Parkinson's Disease Antagonistic network signature of motor function in Parkinson's disease revealed by connectome-based predictive modeling | npj Parkinson's Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41531-022-00315-w/MediaObjects/41531_2022_315_Fig4_HTML.png)
Antagonistic network signature of motor function in Parkinson's disease revealed by connectome-based predictive modeling | npj Parkinson's Disease
![Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/8b2a5b2f-5eb1-4352-a6d9-5280dc343f83/mdc312553-fig-0002-m.jpg)
Progression of MDS‐UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort - Holden - 2018 - Movement Disorders Clinical Practice - Wiley Online Library
![Frontiers | Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease Frontiers | Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease](https://www.frontiersin.org/files/Articles/355629/fneur-09-00260-HTML/image_m/fneur-09-00260-g001.jpg)
Frontiers | Method of Levodopa Response Calculation Determines Strength of Association With Clinical Factors in Parkinson Disease
![A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson's disease | Journal of Neurology, Neurosurgery & Psychiatry A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson's disease | Journal of Neurology, Neurosurgery & Psychiatry](https://jnnp.bmj.com/content/jnnp/93/6/617/F1.large.jpg)
A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson's disease | Journal of Neurology, Neurosurgery & Psychiatry
![Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts - The Lancet Neurology Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts - The Lancet Neurology](https://www.thelancet.com/cms/attachment/4fdb2f29-89cf-4c0e-b751-651ee2b4dee5/gr1_lrg.jpg)
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts - The Lancet Neurology
![PDF) Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity PDF) Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity](https://i1.rgstatic.net/publication/349182863_Quantitative_mobility_measures_complement_the_MDS-UPDRS_for_characterization_of_Parkinson's_disease_heterogeneity/links/60a32693a6fdccb8dc61886a/largepreview.png)